KEVIN SNODDY: Open Payments
NPI 1902129794 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,112 in 80 payments from 18 companies in 2025. Trend: 2023 $1,734 · 2024 $1,799 · 2025 $2,112
Food & beverage: $1,845Education: $267
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $455 |
| Astellas Pharma US Inc | 3 | $212 |
| Sumitomo Pharma America, Inc. | 10 | $198 |
| Dendreon Pharmaceuticals LLC | 8 | $188 |
| Telix Pharmaceuticals | 7 | $158 |
| Boston Scientific Corporation | 5 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $127 |
| Endo USA, Inc. | 5 | $103 |
| ABBVIE INC. | 4 | $88 |
| PFIZER INC. | 4 | $87 |
Products named: ERLEADA, PROVENGE, ILLUCCIX, ORGOVYX, XTANDI, RYBREVANT, Moses, Nubeqa.
Industry payments across NV — which companies pay providers there.
